Blackrock, INC Schedule 13G passive stakes
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, revealing a 15.2% beneficial ownership stake in TTM Technologies Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 10.1% Stake in Regency Centers Corp
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 10.1% in Regency Centers Corp's common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 14.6% Stake in Addus HomeCare Corp
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 14.6% of Addus HomeCare Corp's common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Stake in Boise Cascade Co to 15.5%
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 15.5% in Boise Cascade Co's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 13.4% beneficial ownership stake in G-III Apparel Group Ltd., held for passive investment purposes.
NYSE
SCHEDULE 13G/A: BlackRock Maintains Significant 11.7% Stake in FB Financial Corp, Reinforcing Passive Investment Stance
BlackRock, Inc. has filed an amended Schedule 13G, disclosing its continued beneficial ownership of 11.7% of FB Financial Corp's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 15.3% of PROG Holdings, Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 16.9% Stake in Summit Hotel Properties, Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 16.9% of Summit Hotel Properties, Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Maintains Significant Stake in New Jersey Resources Corp, Holding 15.3% of Common Stock
BlackRock, Inc. has filed an Amendment No. 4 to Schedule 13G, reaffirming its substantial beneficial ownership of 15.3% in New Jersey Resources Corp as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 4 to its Schedule 13G, disclosing an 11.8% beneficial ownership stake in ExlService Holdings, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 4 to its Schedule 13G, disclosing a 14.2% beneficial ownership stake in Nextracker Inc.'s Class A Stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 10.8% Stake in DoubleVerify Holdings, Inc.
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 10.8% beneficial ownership stake in DoubleVerify Holdings, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 14.8% beneficial ownership stake in Archrock, Inc. common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 14.6% of Berkshire Hills Bancorp Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting a 15.2% beneficial ownership stake in AMERISAFE INC as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Stake in Brinker International to 14.7%
BlackRock, Inc. has disclosed an increased passive ownership stake of 14.7% in Brinker International, Inc., holding 6,545,938 shares as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 10% Stake in Core & Main, Inc. Class A Stock
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 10.0% of Core & Main, Inc.'s Class A Stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 4.7% Stake in TriNet Group, Inc. via Amended Schedule 13G Filing
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 4.7% of TriNet Group, Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 5.0% Stake in CRH Public Ltd Co Common Stock
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 5.0% of CRH Public Ltd Co's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 4.5% of Infosys Ltd's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 4.7% beneficial ownership stake in SIGA Technologies Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in RAPT Therapeutics, Inc., Disclosing 1.7% Passive Ownership
BlackRock, Inc. has filed an Amendment No. 4 to its Schedule 13G, reporting a 1.7% beneficial ownership stake in RAPT Therapeutics, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 4.9% passive beneficial ownership stake in Nutrien Ltd. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 4.6% beneficial ownership stake in TechnipFMC plc as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Passive Stake in Taiwan Semiconductor Manufacturing Co. Ltd., Holding 4.4% of Common Stock
BlackRock, Inc. has filed an Amendment No. 3 to its Schedule 13G, disclosing a passive beneficial ownership of 4.4% in Taiwan Semiconductor Manufacturing Co. Ltd. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in Spectrum Brands Holdings, Reports 4.5% Beneficial Ownership
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 4.5% beneficial ownership stake in Spectrum Brands Holdings, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 4.7% beneficial ownership stake in AEGON LTD. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 4.7% of the common stock in Descartes Systems Group Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 5.0% Passive Stake in Townsquare Media, Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 5.0% beneficial ownership stake in Townsquare Media, Inc.'s Class A Stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Passive Stake in Apellis Pharmaceuticals, Holding 4.5% of Common Stock
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 4.5% passive ownership stake in Apellis Pharmaceuticals, Inc. as of March 31, 2025.